Intrust Bank Na Astrazeneca PLC Transaction History

Intrust Bank Na

$995 Million
Q3 2024

A detailed history of Intrust Bank Na transactions in Astrazeneca PLC stock. As of the latest transaction made, Intrust Bank Na holds 13,708 shares of AZN stock, worth $920,903. This represents 0.11% of its overall portfolio holdings.

Number of Shares

13,708

Previous 12,908 6.2%

Holding current value

$920,903

Previous $1.01 Million 6.16%

% of portfolio

0.11%

Previous 0.11%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$76.67 - $87.62 $61,336 - $70,096	800 Added 6.2%	13,708 $1.07 Million
Q2 2024 Aug 08, 2024	BUY	$66.81 - $80.83 $67,678 - $81,880	1,013 Added 8.52%	12,908 $1.01 Million
Q1 2024 May 09, 2024	SELL	$61.03 - $69.57 $69,940 - $79,727	-1,146 Reduced 8.79%	11,895 $805,000
Q4 2023 Feb 05, 2024	SELL	$61.89 - $69.28 $4,084 - $4,572	-66 Reduced 0.5%	13,041 $878,000
Q3 2023 Nov 13, 2023	BUY	$64.85 - $71.7 $28,339 - $31,332	437 Added 3.45%	13,107 $887,000
Q2 2023 Aug 10, 2023	BUY	$69.91 - $75.81 $20,134 - $21,833	288 Added 2.33%	12,670 $906,000
Q1 2023 May 04, 2023	BUY	$63.15 - $71.6 $63,339 - $71,814	1,003 Added 8.81%	12,382 $859,000
Q4 2022 Feb 10, 2023	BUY	$54.21 - $70.44 $82,887 - $107,702	1,529 Added 15.52%	11,379 $771,000
Q3 2022 Nov 09, 2022	SELL	$53.02 - $135.75 $130,747 - $334,759	-2,466 Reduced 20.02%	9,850 $540,000
Q2 2022 Aug 16, 2022	BUY	$59.26 - $71.14 $36,800 - $44,177	621 Added 5.31%	12,316 $814,000
Q1 2022 May 10, 2022	BUY	$55.72 - $67.12 $118,850 - $143,166	2,133 Added 22.31%	11,695 $775,000
Q4 2021 Feb 03, 2022	BUY	$54.02 - $63.83 $1,728 - $2,042	32 Added 0.34%	9,562 $557,000
Q3 2021 Nov 04, 2021	BUY	$55.56 - $60.79 $223,740 - $244,801	4,027 Added 73.18%	9,530 $572,000
Q2 2021 Aug 05, 2021	BUY	$48.42 - $60.18 $18,690 - $23,229	386 Added 7.54%	5,503 $330,000
Q1 2021 Jun 02, 2021	BUY	$47.16 - $54.44 $241,317 - $278,569	5,117 New	5,117 $254,000
Q4 2020 Feb 10, 2021	SELL	$48.52 - $58.02 $183,648 - $219,605	-3,785 Closed	0 $0
Q2 2020 Aug 05, 2020	SELL	$43.1 - $55.31 $40,341 - $51,770	-936 Reduced 19.83%	3,785 $200,000
Q4 2019 Feb 07, 2020	SELL	$42.46 - $50.46 $2,844 - $3,380	-67 Reduced 1.4%	4,721 $236,000
Q3 2019 Nov 12, 2019	SELL	$40.12 - $45.47 $26,278 - $29,782	-655 Reduced 12.03%	4,788 $214,000
Q2 2019 Aug 12, 2019	SELL	$37.28 - $41.68 $37,056 - $41,429	-994 Reduced 15.44%	5,443 $225,000
Q1 2019 May 10, 2019	SELL	$35.49 - $43.02 $73,499 - $89,094	-2,071 Reduced 24.34%	6,437 $261,000
Q4 2018 Feb 06, 2019	SELL	$36.86 - $41.49 $32,141 - $36,179	-872 Reduced 9.3%	8,508 $324,000
Q3 2018 Nov 09, 2018	SELL	$34.76 - $39.72 $29,928 - $34,198	-861 Reduced 8.41%	9,380 $372,000
Q2 2018 Aug 08, 2018	SELL	$34.55 - $37.05 $15,201 - $16,301	-440 Reduced 4.12%	10,241 $360,000
Q1 2018 May 03, 2018	SELL	$32.97 - $36.63 $89,645 - $99,596	-2,719 Reduced 20.29%	10,681 $374,000
Q4 2017 Feb 08, 2018	BUY	$32.09 - $34.78 $24,324 - $26,363	758 Added 6.0%	13,400 $465,000
Q3 2017 Nov 06, 2017	BUY	$28.96 - $34.0 $366,112 - $429,828	12,642	12,642 $428,000

Others Institutions Holding AZN

# of Institutions

1,361

Shares Held

475M

Call Options Held

5.39M

Put Options Held

3.75M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $208B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Intrust Bank Na, based on Form 13F filings with the SEC.

News

Stay updated on Intrust Bank Na with notifications on news.

Account